ASH
Most Read
STAT Plus: With new data and a storied history, Eli Lilly’s blood cancer pill is looking stronger
STAT Plus: Constellation’s blood cancer drug shows greater benefit, easing concerns about its future
STAT Plus: J&J’s CAR-T drug maintains strong efficacy in myeloma, shaded by neurotoxicity
STAT Plus: Genetically targeted drug from Kura Oncology induces remissions in adult leukemia patients
STAT Plus: Preliminary but ‘nothing short of great.’ New data on CRISPR treatment for blood diseases suggest cure is possible
STAT Plus: Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’
